Categories
earning

Syngenta reports 1H 08 results

Reading Time: < 1 minute

Syngenta logo

Highlights
From its IR web site

  • Sales up 20 percent at constant exchange rates to $7.3 billion
  • Crop Protection sales up 21 percent(2) at $5.55 billion
  • Seeds sales up 15 percent(2) to $1.74 billion
  • Earnings per share(1) up 36 percent to $16.53
  • Earnings per share $15.93 after restructuring and impairment
  • Capacity expansion to meet longer term demand growth

  • Video
    CEO interview (cantos, free registrastion required, look for Syngenta).

    Categories
    earning

    China Mobile, Syngenta update

    Reading Time: < 1 minute

    In last two days China Mobile (NYSE:CHL) and Syngenta (NYSE:SYT) released its Q1 results (Bloomberg: CHL result, SYT result). Both are doing very well lately. Today CHL got an upgrade from Zacks. But let’s not got too excited on the stocks, as a general rule. Also keep in mind sometimes we could use the analyst upgrade or downgrade as an opposite indicator (market sentiment).

    Remember a company’s fundamental does not change before and after an analyst wrote a report.

    China Mobile’s strength or new growth mainly comes from the rural areas, and data/internet plan in urban areas. While I apploud its management’s forward looking strategy, I am not sure how long this momentum can sustain. Note CHL trades at a much higher price compared to other mobile operators, and it is the No. 1 carrier in the world according to market cap. Here is another interesting Chinese article about China Mobile (from Caijing).

    Categories
    Business

    Swap Mindray for Syngenta

    Reading Time: 2 minutes

    I sold some Mindray stocks (MR) last Friday and today, and I bought some Syngenta (SYT), the European agriculture company. I think it is a more reasonably valued stock (compared to my across street neighbour Monsanto), in this ag (soft commodity) boom. The thing I want to make sure is it does not bust very soon.

    Syngenta field logo

    The reasons why I sold Mindray:

    1) Before and after it announced the acquisition of DataScope patient monitor business, the stock price dropped quite a bit (note this is quite normal in acquisition);